510 related articles for article (PubMed ID: 12571364)
1. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
Proudfoot AE; Handel TM; Johnson Z; Lau EK; LiWang P; Clark-Lewis I; Borlat F; Wells TN; Kosco-Vilbois MH
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1885-90. PubMed ID: 12571364
[TBL] [Abstract][Full Text] [Related]
2. The biological relevance of chemokine-proteoglycan interactions.
Proudfoot AE
Biochem Soc Trans; 2006 Jun; 34(Pt 3):422-6. PubMed ID: 16709177
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycans mediate cell surface oligomerization of chemokines.
Hoogewerf AJ; Kuschert GS; Proudfoot AE; Borlat F; Clark-Lewis I; Power CA; Wells TN
Biochemistry; 1997 Nov; 36(44):13570-8. PubMed ID: 9354625
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta.
Koopmann W; Ediriwickrema C; Krangel MS
J Immunol; 1999 Aug; 163(4):2120-7. PubMed ID: 10438952
[TBL] [Abstract][Full Text] [Related]
5. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
Ali S; Robertson H; Wain JH; Isaacs JD; Malik G; Kirby JA
J Immunol; 2005 Jul; 175(2):1257-66. PubMed ID: 16002730
[TBL] [Abstract][Full Text] [Related]
6. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
[TBL] [Abstract][Full Text] [Related]
7. Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists.
Brandner B; Rek A; Diedrichs-Möhring M; Wildner G; Kungl AJ
Protein Eng Des Sel; 2009 Jun; 22(6):367-73. PubMed ID: 19414521
[TBL] [Abstract][Full Text] [Related]
8. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.
Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H
Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249
[TBL] [Abstract][Full Text] [Related]
9. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
10. Dentin sialoprotein and phosphoprotein induce neutrophil recruitment: a mechanism dependent on IL-1beta, TNF-beta, and CXC chemokines.
Silva TA; Lara VS; Silva JS; Garlet GP; Butler WT; Cunha FQ
Calcif Tissue Int; 2004 Jun; 74(6):532-41. PubMed ID: 15354861
[TBL] [Abstract][Full Text] [Related]
11. Determination of chemokine-glycosaminoglycan interaction specificity.
Kawashima H
Methods Enzymol; 2006; 416():254-63. PubMed ID: 17113871
[TBL] [Abstract][Full Text] [Related]
12. Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis.
Ali S; Palmer AC; Fritchley SJ; Maley Y; Kirby JA
Biochem J; 2001 Sep; 358(Pt 3):737-45. PubMed ID: 11535134
[TBL] [Abstract][Full Text] [Related]
13. Chemokines have diverse abilities to form solid phase gradients.
Patel DD; Koopmann W; Imai T; Whichard LP; Yoshie O; Krangel MS
Clin Immunol; 2001 Apr; 99(1):43-52. PubMed ID: 11286540
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.
McCornack MA; Boren DM; LiWang PJ
Biochemistry; 2004 Aug; 43(31):10090-101. PubMed ID: 15287737
[TBL] [Abstract][Full Text] [Related]
15. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
Stanford MM; Issekutz TB
J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
[TBL] [Abstract][Full Text] [Related]
16. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention.
Johnson Z; Proudfoot AE; Handel TM
Cytokine Growth Factor Rev; 2005 Dec; 16(6):625-36. PubMed ID: 15990353
[TBL] [Abstract][Full Text] [Related]
17. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
Leach K; Charlton SJ; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice.
Liu W; Nakamura H; Shioji K; Tanito M; Oka S; Ahsan MK; Son A; Ishii Y; Kishimoto C; Yodoi J
Circulation; 2004 Sep; 110(10):1276-83. PubMed ID: 15337697
[TBL] [Abstract][Full Text] [Related]
19. Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance.
Colditz IG; Schneider MA; Pruenster M; Rot A
Thromb Haemost; 2007 May; 97(5):688-93. PubMed ID: 17479178
[TBL] [Abstract][Full Text] [Related]
20. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
Crijns H; Vanheule V; Proost P
Front Immunol; 2020; 11():483. PubMed ID: 32296423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
